As many as 50% of Roswell Park patients are eligible for a clinical trial and participation is entirely up to the patient.
Clinical Trials
With their expertise in clinical skills and medication management, oncology pharmacists are an integral part of that interdisciplinary team.
Cancers that have KRAS mutations are often more difficult to treat, don’t respond as well to standard therapies, are more likely to spread and have poorer prognosis.
Based on their findings, Drs. Yendamuri and Barbi designed a phase 2 clinical trial to see whether metformin might also help prevent lung cancer in overweight or obese people who are at high risk for the disease.
Breakthroughs in cancer research are always something to celebrate. This year marks the 20th anniversary of a particular breakthrough in lung cancer treatment — the discovery of the EGFR gene mutation — that revolutionized how oncologists personalized treatment to each lung cancer patient.
Every year, more than 4,000 children and teens in the U.S. develop brain and spinal cord tumors, which are second only to leukemia as the most common childhood cancers. Can SurVaxM, a pioneering brain cancer immunotherapy developed at Roswell Park, work for younger patients?
Fortunately, Roswell Park had a clinical trial that Edith participated in, and that made her cancer go away in both her breast and lymph nodes.
"Right from the start, everyone was great about getting my appointments for evaluation and treatment set up. Two weeks later I was getting my testing done."
As a sports and news photojournalist for a Buffalo television station, J.T. Messinger is used to seeing the world through a camera lens.
“Roswell Park is at the forefront of research on gastroesophageal cancer, and these studies are aiming to improve the efficacy of chemotherapy, immunotherapy and radiation in patients.”
The groundbreaking lung cancer immunotherapy drug CIMAvax-EGF is now being studied in the prevention of the disease.
Because Roswell Park conducted some of the first clinical trials for the drug, patients here have had early access to this novel targeted anticancer therapy.